Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer

Condition:   Head and Neck Neoplasms
Interventions:   Biological: Durvalumab;   Biological: Cetuximab;   Radiation: Intensity modulated radiation therapy (IMRT)
Sponsor:   Azienda Ospedaliero-Universitaria Careggi
Not yet recruiting - verified February 2017

http://ift.tt/2kt1IYV